Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: GENCYTE THERAPEUTICS INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-02-27 to 2024-02-26
Current total value of award: $299964
Description: GENCYTE THERAPEUTICS, INC. PROPOSES DEVELOPING A SYNTHETIC NOTCH RECEPTOR (SYNNOTCH) CONTROLLED PRECISION MOLECULAR ADAPTOR (PMA) SYSTEM, NAMEDED SYNNOTCH PMA CAR, FOR JMML TREATMENT. THIS PROPOSED PLATFORM TECHNOLOGY COULD POTENTIALLY LOWER CAR-T TO